Axial Therapeutics
PrivateLast Round
Series D
Oct 21, 2025
Total Funding Raised
$101.4M
Company Overview
Vertero Therapeutics is a biotechnology company that develops oral small molecule therapeutics targeting the peripheral nervous system to treat neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axial Therapeutics Comparables
Compare Axial Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterin | 86% | |
| Stellate Therapeutics Inc. | 81% | |
| Viage Therapeutics | 80% | |
Axial Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 21, 2025 | ||||
| Series C | Oct 13, 2021 | ||||
| Series B | Feb 27, 2019 | ||||
| Series A | Nov 30, 2016 |
Axial Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series D, Series C |
| Domain Associates | Series B, Series C, Series A |
| Taiho Ventures | Series C |
| Kairos Ventures | Series A |
| Corundum Systems Biology | Series C |
| Longwood Fund | Series B, Series C, Series A |
| Autism Impact Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2019
$25M round led by Seventure Partners
Axial Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axial Therapeutics's valuation, stock price, and market status.